Skip Page Header

Home > Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

[img] PDF (Report on the risk assessment of 4-methylamphetamine) - Published Version
773kB

This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug in the European Union led to an assessment of the health and social risks posed by the substance, and, consequently, its control across the EU Member States.

Table of contents:
• Foreword
• Introduction
• EMCDDA actions on monitoring and responding to new drugs
• EMCDDA–Europol Joint Report on 4-methylamphetamine: a summary
• Risk Assessment Report of a new psychoactive substance: 4-methylamphetamine
• Annex 1: Technical report on 4-methylamphetamine
• Annex 2: Computational analysis on the pharmacology of 4-methylamphetamine
• Council Decision 2013/129/EU on subjecting 4-methylamphetamine to control measures
• Abbreviations
• Participants of the risk assessment meeting


Item Type
Report
Date
January 2014
Pages
59 p.
Publisher
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
ISBN
978-92-9168-601-8
EndNote
Accession Number
HRB (Electronic Only)
Related URLs

Repository Staff Only: item control page